Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/17/2018 01/18/2018 01/19/2018 01/22/2018 01/23/2018 Date
19.41(c) 18.83(c) 19.03(c) 20.92(c) 21.63(c) Last
855 318 497 008 525 249 1 675 953 2 783 056 Volume
+2.16% -2.99% +1.06% +9.93% +3.39% Change
More quotes
Financials ($)
Sales 2017 132 M
EBIT 2017 -76,2 M
Net income 2017 -86,0 M
Debt 2017 -
Yield 2017 -
Sales 2018 129 M
EBIT 2018 -81,0 M
Net income 2018 -96,2 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 16,0x
Capi. / Sales2018 16,4x
Capitalization 2 106 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products.It targets non-Hodgkin's lymphoma, advanced metastatic colorectal cancer, acute lymphoblastic leukemia, and multiple myeloma.It operates through... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
02:13p SPECTRUM PHARMACEUTICALS, INC. : Today’s Research Reports on Trending Tickers: S..
01:01p SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Noble Capital Mark..
01/19 SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8..
01/08 SPECTRUM PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements an..
2017 SPECTRUM PHARMACEUTICALS, INC. (NASD : SPPI) Files An 8-K Regulation FD Disclosu..
2017 SPECTRUM PHARMACEUTICALS INC : Regulation FD Disclosure (form 8-K)
2017 SPECTRUM PHARMACEUTICALS : Announces Leadership Changes
2017 SPECTRUM PHARMACEUTICALS, INC. (NASD : SPPI) Files An 8-K Departure of Directors..
2017 SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Regula..
2017 SPECTRUM PHARMACEUTICALS : Announces Leadership Changes
More news
Sector news : Biotechnology & Medical Research - NEC
08:48a Drug Firms Bet Billions on Biotech -- WSJ
01/22 Stocks hit record as senators reach deal to end shutdown
01/22 Big Drugmakers Pay Big Prices for Promising Biotechs
01/22 Dealmaking drives European stocks as equity melt-up continues
01/22 Biotech M&A takes off as Sanofi and Celgene spend $20 billion
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
02:13pSpectrum Pharmaceuticals, Inc. : Today’s Research Reports on Trending Tickers.. 
01:10pSpectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Mar.. 
01:04p$SPPI Spectrum Pharmaceuticals to Present Corporate Update at the Noble Capit.. 
01:03pSpectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Mar.. 
01:01pSpectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Mar.. 
More tweets
Qtime:60
News from SeekingAlpha
01/14 GLOBAL BLOOD THERAPEUTICS : What The Recent FDA Breakthrough Therapy Designation..
01/11 4th-Quarter 2017 Portfolio Review And Price Increase For Integrated BioScI In..
01/10 When The Bulls Growl And The Bears Moo - Stock Market Outlook 2018
2017 SPECTRUM PHARMACEUTICALS : Buy The Dip
2017 Top 2017 YTD performers - healthcare
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Technical analysis trends SPECTRUM PHARMACEUTICALS,
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 28,3 $
Spread / Average Target 35%
EPS Revisions
Managers
NameTitle
Joseph W. Turgeon President, Chief Executive Officer & Director
Stuart Mitchell Krassner Chairman
Thomas J. Riga Chief Operating Officer
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
Luigi Lenaz Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SPECTRUM PHARMACEUTICALS, INC.0.42%2 106
CELLTRION, INC.--.--%32 824
IQVIA HOLDINGS INC5.21%21 389
LONZA GROUP2.62%20 968
INCYTE CORPORATION-1.64%19 854
ALNYLAM PHARMACEUTICALS, INC.-1.75%12 881